7,8-dihydroxy-3-phenyl-2H-chromen-2-one (13)
A mixture of 2,3,4-trihydroxybenzaldehyde (1.0 g, 6.5 mmol), phenylacetic acid (1.3 g, 9.7 mmol), and sodium acetate(1.6 g 19.5 mmol ) in 20 mL acetic anhydride was heated with stirring at 160 °C for 6 h. After removal of acetic acid by distillation, the resulting mixture was treated with 2.0 N hydrochloric acid, and the precipitates were collected by filtration. The dried product was recrystallized from ethanol to afford compound 13 (950 mg) in 58% yield as a pale yellow solid. 52, 150.09, 143.67, 142.16, 135.67, 132.31, 128.78, 128.61, 128.42, 122.42, 119.68, 113.27, 113.26 7,8-dihydroxy-2-oxo-2H-chromene-3-carbonitrile (14) 2,3,4-trihydroxybenzaldehyde (1.0 g, 6.5 mmol), malononitrile (0.64 g, 9.7 mmol) and ammonium acetate (0.75 g, 9.7 mmol) were mixed in 20 mL of water. The reaction mixture was stirred under the room temperature for 3h. The resulted solid was filtered and washed three times with 10 mL of water.
Next, the products were added in 20 mL 3N hydrochloric acid solution, and the reaction mixture was stirred at 75 o C for 1h. After reaction, the reaction mixture was cooled to room temperature. 
3-acetyl-7,8-dihydroxy-2H-chromen-2-one (15)
To a solution of 2,3,4-trihydroxybenzaldehyde (1.0 g, 6.5 mmol) and ethyl acetoacetate (1.0 ml, 8.5 mmol) in MeOH (15 ml) was added piperidine (0.1 ml). Then the reaction mixture was heated to reflux for 5 h. After cooling, the reaction mixture was poured slowly into a mixture of ice-water (50 ml) with stirring. The resultant suspension was filtered, and the collected solid was washed with water and dried, then the crude compound was recrystallized from methanol to afford compound 15 (1.2 g) in 85% yield as a yellow solid. 
3-(benzo[d]thiazol-2-yl)-7,8-dihydroxy-2H-chromen-2-one (19)
To a solution of 2,3,4-trihydroxybenzaldehyde (1.0 g, 6.5 mmol) and ethyl 2-(benzo[d]thiazol-2-yl) acetate (1.6 ml, 7.2 mmol) in MeOH (15 ml) was added piperidine (0.1 ml). Then the reaction mixture was heated to 40 °C and stirred for 5 h. After cooling, the reaction mixture was poured -S5-slowly into a mixture of ice-water (50 ml) with stirring. -S6-
Metabolic stability assay in vitro
To determine the effects of a combination of glucuronidation and methylation, daphnetin and compound 9 were incubated with S9 fraction in the presence of two cofactors (2 mM UDPGA and 0.2 mM SAM). The incubation mixture contained pooled human S9 fraction (0.02 mg mL -1 protein), 5 mM MgCl 2 , 2 mM UDPGA, 0.2 mM SAM and 5 mM daphnetin derivatives (dissolved in DMSO, final concentration 1%) in 200 mL of 50 mM Tris buffer (pH 7.4), as described in the reported manuscript. Controls were incubated in the absence of UDPGA and SAM. After incubation at 37 °C for 0 to 60 min, the reactions were terminated by adding 200 mL of cold acetonitrile. The samples were centrifuged at 20 000 g for 20 min. The supernatants (200 mL) were subjected to assay for the time-dependent esculetins depletion using HPLC.
Daphnetin and compound 9 were analyzed by a ultra-fast liquid chromatography spectrometry system (Shimadzu, To determine the value of in vitro in vitro half-life (t 1/2 ), peak areas of parent drug at each time point are tabulated and expressed as a percent of the peak area at the zero minute time point, which represents 100%. t 1/2 was determined using the equation: t 1/2 = ln2/-k, where k represents the terminal elimination rate constant and is calculated as the negative slope of the line defined by the linear regression of the natural log loss of substrate and incubation time (Fig. S1 ).
-S7- Figure S1 . Plot of incubation time vs. natural log percent remaining.
-S8-
S1
. 1 H NMR and 13 C NMR spectra for the synthetic compounds
